Metformin Hydrochloride

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride, is a Biguanide presented as an oral tablet for oral use. It is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus and related insulin‑resistant conditions.

GNH USA supplies Metformin Hydrochloride as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is an oral antidiabetic that targets glucose metabolism in type 2 diabetes and related metabolic disorders. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome (off‑label): improves insulin sensitivity and may restore ovulatory function.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: long‑term use may lower B12 levels.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatotoxicity: liver injury in susceptible individuals. - Hypoglycemia: when combined with insulin or secretagogues. - Pancreatitis: inflammation of the pancreas. - Acute renal failure: especially in dehydration or renal impairment.

Metformin Hydrochloride requires careful assessment before and during therapy. - Renal function assessment: evaluate eGFR prior to initiation and periodically thereafter. - Hepatic function monitoring: avoid use in patients with significant liver disease. - Lactic acidosis risk: discontinue if patient develops severe infection, hypoxia, or acute heart failure. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Drug interaction review: assess concomitant medications that may affect renal clearance. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol excess: heightens risk of lactic acidosis. - Other biguanides: additive risk of toxicity. - Renal‑impairing drugs: such as NSAIDs, may reduce metformin clearance.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal function and electrolyte balance. - ACE inhibitors/ARBs: monitor renal parameters. - Calcium channel blockers: may modestly increase metformin levels. - Sulfonylureas: combined therapy raises hypoglycemia risk.